Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on September 9, 2025

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- OptimizeRx (the “Company”) …

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025
DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All- …

Picard Medical, Inc. Announces Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
TUCSON, Ariz., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that the underwriters of its previously announced initial public offering of common stock, par value $0.0001 per share …

Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance
MINNEAPOLIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (“Celcuity”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it has entered into an amendment to its existing senior secured …

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that a late-breaking oral …

Generative Engine Optimization (GEO): The New Frontier of Digital Visibility
As consumers shift from Google to AI assistants like ChatGPT …

GARC: Renewed dedication to global rabies elimination efforts
GARC rebrands to renew its mission to end rabies by empowering communities, strengthening capacity, and driving global action. MANHATTAN, KS, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Since 2007, GARC has been the leading non-profit …

Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Transaction structured to provide flexible funding to support Phase 1b registrational clinical study program in advanced Parkinson’s under the 505(b)(2) NDA pathway Evaluating complementary funding including strategic equity and non-dilutive alternatives …

Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
Risk adjusted Net Present Value (rNPV) for TVGN 116 is estimated to exceed ~$325 million in the US alone. WARREN, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today shared asset value and …

KFSHRC Concludes Strategic Role at C3 Davos of Healthcare New York Summit
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …

Why Most Global Expansions Fail and What Successful Brands Do to Avoid It
What brands must know before crossing borders—culture, regulation, distribution, and local execution—told through iconic cases. LONDON, GREATER LONDON, UNITED KINGDOM, September 9, 2025 /EINPresswire.com/ -- What do Ferrari, TikTok, and Durex have in …

EsteFavor Hair Transplant Clinic Introduces AI-Powered Preview Technology for Patients Worldwide
EsteFavor launches AI preview system to help patients see realistic post-transplant results and ensure transparency in hair restoration. ISTANBUL, ISTANBUL, TURKEY, September 9, 2025 /EINPresswire.com/ -- EsteFavor Hair Transplant Clinic has officially …

Voice Clinic Services Market to Reach US$ 5.7 Billion by 2035, Boosted by AI and Growing Vocal Health Needs
Prominent players in the market are Nuance Communications, Microsoft Corporation, Amazon Web Services (AWS), Google LLC, Apple Inc, IBM Corporation ROCKVILLE, MD , MD, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- The global voice clinic …

Decisyon Launches AI-Powered Lean Manufacturing Optimizer to Digitalize and Accelerate Shop Floor Innovation
Decisyon’s Lean Manufacturing Optimizer’s embedded AI agents radically improve speed, accuracy …

OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General Meeting of September 30, 2025 Nantes, September 9, 2025, 8:30 p.m. CET - OSE Immunotherapeutics SA (ISIN: …

Le Conseil d’Administration appelle à soutenir une stratégie créatrice de valeur et une gouvernance ouverte - Publication des documents de convocation à l’Assemblée Générale Mixte du 30 septembre 2025
Le Conseil d’Administration appelle à soutenir une stratégie créatrice de valeur et une gouvernance ouverte Publication des documents de convocation à l’Assemblée Générale Mixte du 30 septembre 2025 NANTES, France – 9 septembre 2025, 20 heures 30 – OSE …

Althera Laboratories Announces GMP Approval of State-of-the-Art Pharmaceutical Manufacturing Facility
New facility in Mysuru, India, set to produce one billion oral doses annually, strengthening Althera’s supply chain for cardiovascular and metabolic medicines. DUBLIN, DUBLIN, IRELAND, September 9, 2025 /EINPresswire.com/ -- Althera Laboratories Limited …

Primes-maladie 2026 : hausse moyenne de 4% à 5% et de plus de 10% pour certaines caisses
Dans les cas extrêmes, certaines primes pourraient même bondir de plus de 50%. LAUSANNE, VAUD, SWITZERLAND, September 9, 2025 /EINPresswire.com/ -- bonus.ch sur les primes-maladie 2026 : hausse moyenne de 4% à 5% et de plus de 10% pour certaines caisses …

Krankenkassenprämien 2026: Durchschnittliche Erhöhung um 4% bis 5% und um mehr als 10% bei einigen Kassen
In Extremfällen könnten bestimmte Prämien sogar um mehr als 50% in die Höhe schnellen. LAUSANNE, VAUD, SWITZERLAND, September 9, 2025 /EINPresswire.com/ -- bonus.ch zu den Krankenkassenprämien 2026: Durchschnittliche Erhöhung um 4% bis 5% und um mehr …